Gary Foster, MD
Ophthalmology · Fort Collins, CONPI 1730185182
Payments from drug & device makers
Across 590 payments — averaging $764.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon Research LLC$346K
- Alcon$61K
- Bausch & Lomb Americas Inc.$20K
- Rxsight Inc$9K
- Ivantis, Inc$6K
- Rayner Intraocular Lenses Limited$3K
- plus $6K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon Research LLC | 382 | $345,849 |
| Alcon | 95 | $60,887 |
| Bausch & Lomb Americas Inc. | 15 | $19,675 |
| Rxsight Inc | 9 | $9,449 |
| Ivantis, Inc | 4 | $6,313 |
| Rayner Intraocular Lenses Limited | 4 | $2,824 |
| Bausch Health US, LLC | 1 | $1,787 |
| Eyevance Pharmaceuticals LLC | 5 | $1,455 |
| Glaukos Corporation | 5 | $600 |
| NEW World Medical,inc. | 16 | $423 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $202 |
| Sun Pharmaceutical Industries Inc. | 5 | $200 |
| Kala Pharmaceuticals, Inc. | 8 | $165 |
| Tarsus Pharmaceuticals, Inc. | 4 | $164 |
| Ocular Therapeutix, Inc. | 1 | $148 |
| AbbVie(2 entities) | 8 | $135 |
| Lensar, Inc. | 2 | $115 |
| Sight Sciences, Inc. | 4 | $112 |
| Carl Zeiss Meditec USA, Inc. | 1 | $88 |
| Novartis | 3 | $63 |
| Carl Zeiss Meditec, Inc. | 2 | $56 |
| Mallinckrodt Hospital Products Inc. | 3 | $50 |
| Omeros Corporation | 3 | $45 |
| Dompe US, Inc. | 1 | $25 |
| Aerie Pharmaceuticals, Inc. | 1 | $22 |
| Harrow Eye, LLC | 1 | $18 |
| Thea Pharma Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $13 |
How this compares
$450,900 in reported general payments places this provider in the 95th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Fort Collins
- Kent CrewsFort Collins$502K
- Jason MayerFort Collins$167K
- Karl OlsenFort Collins$128K
- Ronald FrenkelFort Collins$52K
- Brittney StatlerFort Collins$27K
- Patrick ArnoldFort Collins$6K
- Mark PackerBoulder$6.6M
- Ryan RichColorado Springs$2.1M
- Michael JansenDenver$1.8M
- Curtis HagedornDenver$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.